Clinical Pharmacokinetics and Pharmacodynamics of Ifosfamide and its MetabolitesDr Thomas Kerbusch, Jan de Kraker, H. Jan Keizer, John W. G. van Putten, Harry J. M. Groen, Rob L. H. Jansen, Jan H. M. Schellens, Jos H. Beijnen · 2001

Mass Balance Studies, with a Focus on Anticancer DrugsDr Jan H. Beumer, Jos H. Beijnen, Jan H. M. Schellens · 2006

Metabolism of trabectedin (ET-743, Yondelis™) in patients with advanced cancerJan H. Beumer; Jeany M. Rademaker-Lakhai; Hilde Rosing; Michel J. X. Hillebrand; Tessa M. Bosch; Luis Lopez-Lazaro; Jan H. M. Schellens; Jos H. Beijnen · 2007

Is rectal administration an alternative route for imatinib?Nielka P. H. van Erp; Roos L. Oostendorp; Henk-Jan Guchelaar; Jan H. M. Schellens; Hans Gelderblom · 2007

ET-743Jos H. Beijnen, Jan H. M. Schellens · 2002

Metabolism of docetaxel in miceHeleen A. Bardelmeijer; Arjan B. G. H. Roelofs; Michel J. X. Hillebrand; Jos H. Beijnen; Jan H. M. Schellens; Olaf van Tellingen · 2005

Screening for polymorphisms in thePXRgene in a Dutch populationTessa M. Bosch; Maarten Deenen; Roelof Pruntel; Paul H. M. Smits; Jan H. M. Schellens; Jos H. Beijnen; Irma Meijerman · 2006

Clinical Pharmacokinetics of Therapeutic Monoclonal AntibodiesRon J. Keizer, Alwin D. R. Huitema, Jan H. M. Schellens, Jos H. Beijnen · 2010

Carcinoma of Unknown Primary SiteVaradhachary, Gauri · JAMA Oncology · 2015

Myeloproliferative NeoplasmsTefferi, Ayalew; Pardanani, Animesh · JAMA Oncology · 2015

Immune Checkpoint InhibitorsWest, Howard (Jack) · JAMA Oncology · 2015

Malignant Pleural EffusionsWest, Howard (Jack) · JAMA Oncology · 2015

Five Years of Cancer Drug ApprovalsMailankody, Sham; Prasad, Vinay · JAMA Oncology · 2015

Circulating Tumor CellsWest, Howard (Jack); Jin, Jill O. · JAMA Oncology · 2015

Neoadjuvant TherapyWest, Howard (Jack); Jin, Jill · JAMA Oncology · 2015

Parkinson Disease and Malignant DiseaseGanguli, Mary; Lotze, Michael T. · JAMA Oncology · 2015